Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Neuroblastoma 5Central Nervous System Neoplasms 4Brain Neoplasms 3Teratoma 2Rhabdoid Tumor 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myeloid, Acute 2Astrocytoma 2Spinal Cord Neoplasms 1Sarcoma 1Myelodysplastic Syndromes 1Medulloblastoma 1Leukemia, Myelomonocytic, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia, Biphenotypic, Acute 1Graft vs Host Disease 1Ganglioneuroblastoma 1Congenital Abnormalities 1Choroid Plexus Neoplasms 1Choriocarcinoma 1Carcinoma, Embryonal 1Breast Neoplasms 1

Interventions

pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1merphos 1Thiotepa 1Specimen Handling 1Second-Look Surgery 1Reoperation 1Radiotherapy 1Radiation 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1Mesna 1Magnetic Resonance Spectroscopy 1Leucovorin 1Ifosfamide 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Dactinomycin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Choriocarcinoma × Thiotepa × Clear all
NCT04684368 2026-05-05

A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCT

Children's Oncology Group

Phase 2 Recruiting
160 enrolled

Choriocarcinoma, Teratoma, Carcinoma, Embryonal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡